Home / Brands / A-S Medication Solutions
A-S Medication Solutions Recalls
9 recalls on record · May 11, 2016 to April 2, 2025 · Drugs
Recalls by year
16
18
21
24
25
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
April 2, 2025DrugsFDA
A-S Medication Solutions LLC recalls METFORMIN HYDROCHLORIDE EXTENDED- RELEASE 500MG, 180 TABLETS, Packaged BY: A-S Medication Solutions, Libertyville, IL 60
Hazard: Presence of Foreign Tablets/Capsules.
August 14, 2024DrugsFDA
A-S Medication Solutions LLC recalls Acetaminophen Extra Strength Tablets, 500 mg each, 100 count bottles, Packaged By: A-S Medication Solutions, Libertyvill
Hazard: Labeling: Label Mix-Up: Some bottles of Acetaminophen Extra Strength 500 mg tablets were incorrectly labeled with the drug facts label for Aspirin 81 mg tablets.
November 17, 2021DrugsFDA
A-S Medication Solutions LLC. recalls Cetirizine hydrochloride, 10 mg tablets, 90-count bottle, Distributed by: A-S Medications Solutions, Libertyville, IL 60
Hazard: Labeling: Not Elsewhere classified: Product was relabeled as 90 tablet count product although it was a manufacturer in a box with 30 tablet count tablets.
May 12, 2021DrugsFDA
A-S Medication Solutions LLC. recalls Acetaminophen, Extra Strength, Aspirin Free, 500 MG Tablets, 100-count bottles, Mfr: Major Pharmaceuticals, Livonia, MI
Hazard: Labeling: Label Mix-up; The bottle of over-the-counter Acetaminophen 500mg Extra Strength, 100 count, included in Health Essential Kits, labeled incorrectly with a prescription drug label instead of an OTC drug label.
August 29, 2018DrugsFDA
A-S Medication Solutions LLC. recalls Valsartan and Hydrochlorothiazide Tablets, Valsartan 320 MG and Hydrochlorothiazide 25 MG, 90 tablets per bottle, Rx Onl
Hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
August 29, 2018DrugsFDA
A-S Medication Solutions LLC. recalls Valsartan and Hydrochlorothiazide Tablets, Valsartan 160 MG and Hydrochlorothiazide 12.5 MG, 90 tablets per bottle, Rx O
Hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
August 29, 2018DrugsFDA
A-S Medication Solutions LLC. recalls Valsartan Tablets, 80 MG, 30-count bottle (NDC 54569-6582-0, 90-count bottle (NDC 54569-6582-1), Rx Only, MFG: Zhejiang
Hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
August 29, 2018DrugsFDA
A-S Medication Solutions LLC. recalls Valsartan Tablets, 160 MG, 30-count bottle (NDC 54569-6583-0), 90-count bottle (NDC 54569-6583-1), Rx Only, MFG: Zhejian
Hazard: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
May 11, 2016DrugsFDA
A-S Medication Solutions LLC. recalls Acetaminophen & Codeine Phosphate Tablets, 300 mg/30 mg, 15-count plastic bottle, Rx only, Mfr: Aurolife Pharma LLC, Day
Hazard: Labeling: Not elsewhere classified - count on the label was incorrect.